Cardiac sarcoidosis: Epidemiology, characteristics, and outcome over 25 years in a nationwide study

Circulation

Volumn 131, Issue 7, 2015, Pages 624-632

  Kandolin, Riina ^a   Lehtonen, Jukka ^a   Airaksinen, Juhani ^b   Vihinen, Tapani ^b   Miettinen, Heikki ^c   Ylitalo, Kari ^d   Kaikkonen, Kari ^d   Tuohinen, Suvi ^e   Haataja, Petri ^e   Kerola, Tuomas ^f   Kokkonen, Jorma ^g   Pelkonen, Markus ^h   Pietilä Effati, Päivi ⁱ   Utrianen, Seppo ^j   Kupari, Markku ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d MEDICAL RESEARCH CENTER OULU   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^g CENTRAL FINLAND CENTRAL HOSPITAL   (Finland)

^h SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

ⁱ VAASA CENTRAL HOSPITAL   (Finland)

^j SOUTH KARELIA CENTRAL HOSPITAL   (Finland)

more..

Author keywords

Epidemiology; Prognosis; Sarcoidosis; Therapeutics

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; INFLIXIMAB; METHOTREXATE; PREDNISONE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR CONDUCTION; BREAST CANCER; CEREBROVASCULAR ACCIDENT; CLINICAL EXAMINATION; COLON CANCER; COMPLETE HEART BLOCK; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DIFFUSE LEWY BODY DISEASE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FEMALE; FINLAND; FOLLOW UP; HEART CONDUCTION; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART VENTRICLE FIBRILLATION; HISTOPATHOLOGY; HUMAN; HYPOKALEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSOMNIA; JOINT NECROSIS; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MYOPATHY; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PATIENT; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY; SARCOIDOSIS; STEROID THERAPY; SUDDEN CARDIAC DEATH; SUDDEN DEATH; SURVIVAL RATE; THORAX RADIOGRAPHY; TREATMENT DURATION; CARDIOMYOPATHIES; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; TREATMENT OUTCOME; TRENDS;

ADULT; AGED; CARDIOMYOPATHIES; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOIDOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84923677215     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.011522     Document Type: Article

References (40)

1. Bernstein M, Konzelman FW, Sidlick DM. Boeck's sarcoid: report of a case with visceral involvement. Arch Intern Med. 1929; 44: 721-734.
2. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J. Sarcoidosis. Lancet. 2014; 383: 1155-1167. doi: 10.1016/ S0140-6736(13)60680-7.
3. Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, Izumi T, Homma AH, Mikami R, Hongo O, Hiraga Y, Yamamoto M. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci. 1976; 278: 455-469.
4. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977; 63: 86-108.
5. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978; 58: 1204-1211.
6. Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol. 2009; 104: 571-577. doi: 10.1016/j.amjcard.2009.03.068.
7. Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, Prystowsky S. Cardiac sarcoidosis. Am Heart J. 2009; 157: 9-21. doi: 10.1016/j.ahj.2008.09.009.
8. Dubrey SW, Falk RH. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis. 2010; 52: 336-346. doi: 10.1016/j.pcad.2009.11.010.
9. Blauwet LA, Cooper LT. Idiopathic giant cell myocarditis and cardiac sarcoidosis. Heart Fail Rev. 2013; 18: 733-746. doi: 10.1007/s10741-012-9358-3.
10. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R; Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001; 164(pt 1): 1885-1889. doi: 10.1164/ajrccm.164.10.2104046.
11. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009; 120: 1969-1977. doi: 10.1161/CIRCULATIONAHA.109.851352.
12. Patel AR, Klein MR, Chandra S, Spencer KT, Decara JM, Lang RM, Burke MC, Garrity ER, Hogarth DK, Archer SL, Sweiss NJ, Beshai JF. Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study. Eur J Heart Fail. 2011; 13: 1231-1237. doi: 10.1093/eurjhf/hfr099.
13. Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, Nothnagel D, Bültel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013; 6: 501-511. doi: 10.1016/j.jcmg.2012.10.021.
14. Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, Machac J, Teirstein A. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest. 2008; 133: 1426-1435. doi: 10.1378/chest.07-2784.
15. Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, Bailey KR, Cooper LT. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003; 41: 322-329.
16. Brown ML, Reeder G, Unni KK, Mullany C. Intraoperative diagnosis of isolated cardiac sarcoid. Heart Lung Circ. 2007; 16: 315-317. doi: 10.1016/j.hlc.2006.07.009.
17. Kandolin R, Lehtonen J, Graner M, Schildt J, Salmenkivi K, Kivistö SM, Kupari M. Diagnosing isolated cardiac sarcoidosis. J Intern Med. 2011; 270: 461-468. doi: 10.1111/j.1365-2796.2011.02396.x.
18. Sugizaki Y, Tanaka H, Imanishi J, Konishi A, Yamashita T, Shinke T, Ishida T, Kawai H, Hirata K. Isolated primary cardiac sarcoidosis presenting as acute heart failure. Intern Med. 2013; 52: 71-74.
19. Nery PB, Keren A, Healey J, Leug E, Beanlands RS, Birnie DH. Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy. Can J Cardiol. 2013; 29: 1015. e1-1015.e3. doi: 10.1016/j.cjca.2012.09.009.
20. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, Izumi T, Sekiguchi M; Central Japan Heart Study Group. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001; 88: 1006-1010.
21. Chiu CZ, Nakatani S, Zhang G, Tachibana T, Ohmori F, Yamagishi M, Kitakaze M, Tomoike H, Miyatake K. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol. 2005; 95: 143-146. doi: 10.1016/j.amjcard.2004.08.083.
22. Kato Y, Morimoto S, Uemura A, Hiramitsu S, Ito T, Hishida H. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis. 2003; 20: 133-137.
23. Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL, de Gennes C, Papo T, Blétry O, Godeau P, Piette JC. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore). 2004; 83: 315-334.
24. Sadek MM, Yung D, Birnie DH, Beanlands RS, Nery PB. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol. 2013; 29: 1034-1041. doi: 10.1016/j.cjca.2013.02.004.
25. Hamzeh NY, Wamboldt FS, Weinberger HD. Management of cardiac sarcoidosis in the United States: a Delphi study. Chest. 2012; 141: 154-162. doi: 10.1378/chest.11-0263.
26. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol. 2011; 4: 303-309. doi: 10.1161/ CIRCEP.110.959254.
27. Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, Miura M, Sakaue S, Tamaki N, Nishimura M. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2008; 35: 933-941. doi: 10.1007/s00259-007-0650-8.
28. Youssef G, Beanlands RS, Birnie DH, Nery PB. Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart. 2011; 97: 2078-2087. doi: 10.1136/hrt.2011.226076.
29. Pietinalho A, Hiraga Y, Hosoda Y, Löfroos AB, Yamaguchi M, Selroos O. The frequency of sarcoidosis in Finland and Hokkaido, Japan: a comparative epidemiological study. Sarcoidosis. 1995; 12: 61-67.
30. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997; 145: 234-241.
31. Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP, Maheshwari A, Noguchi TI. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis. 1994; 11: 26-31.
32. Fleming HA. Sarcoid heart disease. Br Heart J. 1974; 36: 54-68.
33. Meyer T, Lauschke J, Ruppert V, Richter A, Pankuweit S, Maisch B. Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology. 2008; 109: 117-121. doi: 10.1159/000105552.
34. Galati G, Leone O, Rapezzi C. The difficult diagnosis of isolated cardiac sarcoidosis: usefulness of an integrated MRI and PET approach. Heart. 2014; 100: 89-90. doi: 10.1136/heartjnl-2013-304237.
35. Donsky AS, Escobar J, Capehart J, Roberts WC. Heart transplantation for undiagnosed cardiac sarcoidosis. Am J Cardiol. 2002; 89: 1447-1450.
36. Tsai JH, Chou NK, Wang SS, Shun CT. Isolated cardiac sarcoidosis: case experience in heart transplantation. J Formos Med Assoc. 2013; 112: 499-500. doi: 10.1016/j.jfma.2011.12.010.
37. Fleming HA, Bailey SM. The prognosis of sarcoid heart disease in the United Kingdom. Ann N Y Acad Sci. 1986; 465: 543-550.
38. Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel AR, Sweiss NJ, Nguyen DT, Aleong RG, Varosy PD, Weinberger HD, Sauer WH. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2012; 23: 925-929. doi: 10.1111/j.1540-8167.2012.02350.x.
39. Yodogawa K, Seino Y, Ohara T, Takayama H, Katoh T, Mizuno K. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011; 16: 140-147. doi: 10.1111/j.1542-474X.2011.00418.x.
40. Kudoh H, Fujiwara S, Shiotani H, Kawai H, Hirata K. Myocardial washout of 99mTc-tetrofosmin and response to steroid therapy in patients with cardiac sarcoidosis. Ann Nucl Med. 2010; 24: 379-385. doi: 10.1007/ s12149-010-0376-8.